Recent Finacing
Recent Raise
Aptamarket develops aptamer-based diagnostic kits for pancreatic cancer using small-molecule-binding aptamers to detect CA19-9 and abnormal metabolites, and is extending into aptamer-targeted therapeutics and cell therapies for acute leukemia.
Focus Areas
Recent Investors
Funding round
Investor